These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26948846)

  • 1. Is there a difference between various presentations of valproate for cognitive outcome after in utero exposure?
    Gelisse P; Genton P; Crespel A
    Epilepsia; 2016 Mar; 57(3):523-4. PubMed ID: 26948846
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive outcome after exposure to antiepileptic drugs in utero.
    Battino D
    Lancet Neurol; 2009 Jul; 8(7):600-1. PubMed ID: 19539227
    [No Abstract]   [Full Text] [Related]  

  • 3. [Position Statement of Hungarian Epilepsy League: The use of valproate preparations for epilepsy in pregnancy and in women of childbearing age].
    Janszky J;
    Ideggyogy Sz; 2015 Mar; 68(3-4):143. PubMed ID: 26434203
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproic acid: long-term effects on children exposed in utero.
    Prescrire Int; 2009 Dec; 18(104):253-7. PubMed ID: 20025093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy: Should valproate be avoided during childbearing years?
    Maccotta L; Sullivan JE
    Nat Rev Neurol; 2009 Aug; 5(8):414-5. PubMed ID: 19657344
    [No Abstract]   [Full Text] [Related]  

  • 7. [Valproate should be avoided in pregnancy].
    Nakken KO; Taubøll E
    Tidsskr Nor Laegeforen; 2014 Jan; 134(2):144-5. PubMed ID: 24477142
    [No Abstract]   [Full Text] [Related]  

  • 8. Developmental neurotoxicity and anticonvulsant drugs: a possible link.
    Verrotti A; Scaparrotta A; Cofini M; Chiarelli F; Tiboni GM
    Reprod Toxicol; 2014 Sep; 48():72-80. PubMed ID: 24803404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.
    Shallcross R; Bromley RL; Cheyne CP; García-Fiñana M; Irwin B; Morrow J; Baker GA; ;
    Neurology; 2014 Jan; 82(3):213-21. PubMed ID: 24401687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversible neuropsychological deterioration associated with valproate].
    Vaquerizo J; Gómez Martín H; González Iglesias E; Cardesa JJ
    Rev Neurol; 1995; 23(119):148-50. PubMed ID: 8548612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproate is contraindicated in pregnancy].
    Olsen DB; Baftiu A
    Tidsskr Nor Laegeforen; 2019 Feb; 139(3):. PubMed ID: 30754942
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
    Viinikainen K; Eriksson K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R
    Epilepsy Behav; 2006 Dec; 9(4):636-40. PubMed ID: 17049311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate and other anticonvulsants for psychiatric disorders.
    Med Lett Drugs Ther; 2000 Dec; 42(1094):114-5. PubMed ID: 11114842
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid.
    Juliandi B; Tanemura K; Igarashi K; Tominaga T; Furukawa Y; Otsuka M; Moriyama N; Ikegami D; Abematsu M; Sanosaka T; Tsujimura K; Narita M; Kanno J; Nakashima K
    Stem Cell Reports; 2015 Dec; 5(6):996-1009. PubMed ID: 26677766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate and childbearing potential: new regulations.
    Sisodiya SM;
    Pract Neurol; 2018 Jun; 18(3):176-178. PubMed ID: 29686038
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiepileptic treatment in pregnant women: morphological and behavioural effects.
    Tomson T; Battino D
    Handb Exp Pharmacol; 2011; 205():295-315. PubMed ID: 21882118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment: valproate dose effects differ across congenital malformations.
    Meador KJ
    Neurology; 2013 Sep; 81(11):1002. PubMed ID: 23911754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
    Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
    Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.